Abstract
Cocrystallization is a very efficient strategy to improve the physicochemical properties of bioactive agents. A new norfloxacin (NOR)–saccharin cocrystal and a cocrystal–solvate were synthesized through the mechanochemical method (neat and liquid-assisted grinding), and the characterization was performed by thermal analysis (TG–DTA, DSC and DSC microscopy), infrared vibrational spectroscopy and powder X-ray diffraction. Moreover, solubility experiments carried out in water and buffer solutions (pH 3.0, 6.1 and 8.5) showed that norfloxacin has an aqueous solubility 3.5 times higher when cocrystallized with saccharin than in its pristine state, and an inverted pH-dependency compared to NOR alone (2 times higher in 6.1, slightly increase in pH 3.0, and a decrease of 0.7 times in 8.5 buffer solution). Furthermore, the solvate–cocrystal has a water solubility 2.3 times higher than NOR and the same solubility in 6.1 buffer solution than the cocrystal (2 times higher than NOR alone).
Similar content being viewed by others
References
Bearden DT, Danziger LH. Mechanism of action of and resistance to quinolones. Pharmacotherapy. 2001;21:224S-232S. https://doi.org/10.1111/j.1751-7915.2008.00063.x.
Vila J. Fluoroquinolone resistance. Front Antimicrob Resist. 2005. https://doi.org/10.1128/9781555817572.chap4.
Norrby SR. Side-effects of quinolones: comparisons between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis. 1991;10:378–83. https://doi.org/10.1007/BF01967014.
Corrado ML, Struble WE, Peter C, Hoagland V, Sabbaj J. Norfloxacin: review of safety studies. Am J Med. 1987;82:22–6.
Holmes B, Brogden RN, Richards DM. Norfloxacin A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985;30:482–513. https://doi.org/10.2165/00003495-198530060-00003.
de Souza JM, Galaverna R, de Souza AAN, Brocksom TJ, Pastre JC, de Souza ROMA, et al. Impact of continuous flow chemistry in the synthesis of natural products and active pharmaceutical ingredients. An Acad Bras Cienc. 2018;90:1131–74.
Elder DP. Effective formulation development strategies for poorly soluble active pharmaceutical ingredients (APIs). Am Pharm Rev 2010 [cited 2019 Sep 19]. https://www.americanpharmaceuticalreview.com/Featured-Articles/114950-Effective-Formulation-Development-Strategies-for-Poorly-Soluble-Active-Pharmaceutical-Ingredients-APIs/.
Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev. 2012;64:480–95.
ICH Harmonised Guideline. Biopharmaceutics classification system-based biowaivers M9. Int Counc Harmon Tech Requir Pharm Hum Use. 2018, p. 19.
Breda SA, Jimenez-Kairuz AF, Manzo RH, Olivera ME. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int J Pharm. 2009;371:106–13.
Savjani J. Co-crystallization: An approach to improve the performance characteristics of active pharmaceutical ingredients. Asian J Pharm. 2015;9:147.
Chaudhari S, Nikam SA, Khatri N, Wakde S. Co-crystals: a review. J Drug Deliv Ther. 2019;8:350–8.
Douroumis D, Ross SA, Nokhodchi A. Advanced methodologies for cocrystal synthesis. Adv Drug Deliv Rev. 2017;117:178–95.
Kavanagh ON, Croker DM, Walker GM, Zaworotko MJ. Pharmaceutical cocrystals: from serendipity to design to application. Drug Discov Today. 2018;21:796–804.
Gajda M, Nartowski KP, Pluta J, Karolewicz B. Continuous, one-step synthesis of pharmaceutical cocrystals via hot melt extrusion from neat to matrix-assisted processing—state of the art. Int J Pharm. 2019;558:426–40. https://doi.org/10.1016/j.ijpharm.2019.01.016.
Park B, Yoon W, Yun J, Ban E, Yun H, Kim A. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility. Int J Pharm. 2019;557:26–35.
Basavoju S, Boström D, Velaga SP. Pharmaceutical cocrystal and salts of norfloxacin. Cryst Growth Des. 2006;6:2699–708. https://doi.org/10.1021/cg060327x.
Velaga SP, Basavoju S, Boström D. Norfloxacin saccharinate-saccharin dihydrate cocrystal—a new pharmaceutical cocrystal with an organic counter ion. J Mol Struct. 2008;889:150–3.
Ferreira LT, Alarcon RT, Perpétuo GL, Bannach G. Investigation and characterization by TG/DTG–DTA and DSC of the fusion of Riboflavin, and its interaction with the antibiotic norfloxacin in the screening of cocrystal. J Therm Anal Calorim. 2019;136:581–8.
Huang XF, Zhang ZH, Zhang QQ, Wang LZ, He MY, Chen Q, et al. Norfloxacin salts with benzenedicarboxylic acids: charge-assisted hydrogen-bonding recognition and solubility regulation. CrystEngComm. 2013;15:6090–100.
Oser BL. Highlights in the history of saccharin toxicology. Food Chem Toxicol. 1985;23:535–42.
Friščić T, Childs SL, Rizvi SAA, Jones W. The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome. CrystEngComm. 2009;11:418–26.
Descamps M, Willart JF. Perspectives on the amorphisation/milling relationship in pharmaceutical materials. Adv Drug Deliv Rev. 2016;100:51–66.
Willart JF, Descamps M. Solid state amorphization of pharmaceuticals. Mol Pharm. 2008;5:905–20. https://doi.org/10.1021/mp800092t.
Cherukuvada S, Guru Row TN. Supporting information—comprehending the formation of eutectics and cocrystals in terms of design and their structural interrelationships. Cryst Growth Des. 2014;14:4187–98. https://doi.org/10.1021/cg500790q.
Cherukuvada S, Nangia A. Eutectics as improved pharmaceutical materials: design, properties and characterization. Chem Commun. 2014;50:906–23.
Kogawa AC, Corrêa JCR, Salgado HRN. Influence of darunavir: β-cyclodextrin complex on the solubility of darunavir. Res Rev J Pharmacol Toxicol Stud. 2014;2:50–5.
Kogawa AC, Peltonen L, Antonio SG, Salgado HRN. Submission of rifaximin to different techniques: characterization, solubility study, and microbiological evaluation. AAPS PharmSciTech. 2019;20:125. https://doi.org/10.1208/s12249-019-1329-8.
Dua K, Ramana M, Singh Sara U, Himaja M, Agrawal A, Garg V, et al. Investigation of enhancement of solubility of norfloxacin & #946;-cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv. 2007;4:21–5.
Chierentin L, Salgado HRN. Performance characteristics of UV and visible spectrophotometry methods for quantitative determination of norfloxacin in tablets. J Sci Res. 2014;6:531–41.
Chongcharoen W, Byrn SR, Sutanthavibul N. Solid state interconversion between anhydrous norfloxacin and its hydrates. J Pharm Sci. 2008;97:473–89. https://doi.org/10.1002/jps.21165.
Tanaka JS, de Salvi S, Antonio SG, de Paiva-Santos C. The use of the software JST-XRD for identifcation of crystalline phases in pharmaceutical raw materials and tablets. J Basic Appl Pharm Sci. 2016;37:2–8.
Nunes WDG, do Nascimento ALCS, Moura A, Gaglieri C, Vallim GB, Nascimento LC, et al. Thermal, spectroscopic and antimicrobial activity characterization of some norfloxacin complexes. J Therm Anal Calorim. 2018;132:1077–88.
Bernal C, Couto AB, Breviglieri ST, Cavalheiro ÉTG. Influência de alguns parâmetros experimentais nos resultados de análises calorimétricas diferenciais—DSC. Quim Nova. 2002;25:849–55.
de Carvalho LC, Segato MP, Nunes RS, Novak C, Cavalheiro ÉTG. Thermoanalytical studies of some sweeteners. J Therm Anal Calorim. 2009;97:359–65. https://doi.org/10.1007/s10973-009-0262-6.
Mazuel C. Norfloxacin. Anal profiles drug Subst. 1991.
Saganowska P, Wesolowski M. DSC as a screening tool for rapid co-crystal detection in binary mixtures of benzodiazepines with co-formers. J Therm Anal Calorim. 2018;133:785–95. https://doi.org/10.1007/s10973-017-6858-3.
Yamashita H, Hirakura Y, Yuda M, Teramura T, Terada K. Detection of cocrystal formation based on binary phase diagrams using thermal analysis. Pharm Res. 2013;30:70–80. https://doi.org/10.1007/s11095-012-0850-1.
Drozd KV, Arkhipov SG, Boldyreva EV, Perlovich GL. Crystal structure of a 1:1 salt of 4-aminobenzoic acid (Vitamin B 10) with pyrazinoic acid. Acta Crystallogr Sect E Crystallogr Commun. 2018;74:1923–7.
de Almeida AC, Torquetti C, Ferreira PO, Fernandes RP, dos Santos EC, Kogawa AC, et al. Cocrystals of ciprofloxacin with nicotinic and isonicotinic acids: mechanochemical synthesis, characterization, thermal and solubility study. Thermochim Acta. 2020;685:178346.
Lin HL, Wu TK, Lin SY. Screening and characterization of cocrystal formation of metaxalone with short-chain dicarboxylic acids induced by solvent-assisted grinding approach. Thermochim Acta. 2014;575:313–21. https://doi.org/10.1016/j.tca.2013.10.029.
Yamashita H, Hirakura Y, Yuda M, Terada K. Coformer screening using thermal analysis based on binary phase diagrams. Pharm Res. 2014;31:1946–57.
Barbas R, Prohens R, Puigjaner C. A new polymorph of norfloxacin. J Therm Anal Calorim. 2007;89:687–92.
Šuštar B, Bukovec N, Bukovec P. Polymorphism and stability of norfloxacin, (1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinil)-3-quinolinocarboxylic acid. J Therm Anal. 1993;40:475–81. https://doi.org/10.1007/BF02546616.
Jayasankar A, Somwangthanaroj A, Shao ZJ, Rodríguez-Hornedo N. Cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm Res. 2006;23:2381–92.
Karimi-Jafari M, Padrela L, Walker GM, Croker DM. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Cryst Growth Des Am Chem Soc. 2018;18:6370–87.
Lien Nguyen K, Friščić T, Day GM, Gladden LF, Jones W. Terahertz time-domain spectroscopy and the quantitative monitoring of mechanochemical cocrystal formation. Nat Mater. 2007;6:206–9.
Velaga SP, Basavoju S, Boström D. Norfloxacin saccharinate–saccharin dihydrate cocrystal—a new pharmaceutical cocrystal with an organic counter ion. J Mol Struct. 2008;889:150–3.
Sahoo S, Chakraborti CK, Behera PK, Mishra SC. FTIR and Raman spectroscopic investigations of a norfloxacin/carbopol934 polymerie suspension. J Young Pharm. 2013;4:138–45.
Puigjaner C, Barbas R, Portell A, Font-Bardia M, Alcobé X, Prohens R. Revisiting the solid state of norfloxacin. Cryst Growth Des. 2010;10:2948–53. https://doi.org/10.1021/cg9014898.
Yu X, Zipp GL, Davidson GW. The effect of temperature and pH on the solubility of quinolone compounds: estimation of heat of fusion. Pharm Res. 1994;11:522–7.
Khankari RK, Grant DJW. Pharmaceutical hydrates. Thermochim Acta. 1995;248:61–79.
Roy S, Goud NR, Babu NJ, Iqbal J, Kruthiventi AK, Nangia A. Crystal structures of norfloxacin hydrates. Cryst Growth Des. 2008;8:4343–6. https://doi.org/10.1134/S1070363213120372.
Acknowledgements
The authors thank CPID/CDMF, FAPESP (Grant Nos. 2013/09022-7, 2017/14936-9, 2018/12463-9 and 2018/24378-6), CNPq (Grant Nos. 421469/2016-1and 159936/2018-7) and CAPES (Grant No. 001) foundations (Brazil) for financial support.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file2 (AVI 8673 KB)
Supplementary file3 (AVI 8585 KB)
Rights and permissions
About this article
Cite this article
Ferreira, P.O., de Moura, A., de Almeida, A.C. et al. Mechanochemical synthesis, thermoanalytical study and characterization of new multicomponent solid forms of norfloxacin with saccharin. J Therm Anal Calorim 147, 1985–1997 (2022). https://doi.org/10.1007/s10973-021-10658-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10973-021-10658-w